The ''Journal of the American Academy of Child and Adolescent Psychiatry'' is a
peer-reviewed
Peer review is the evaluation of work by one or more people with similar competencies as the producers of the work (peers). It functions as a form of self-regulation by qualified members of a profession within the relevant field. Peer review ...
medical journal
A medical journal is a peer-reviewed scientific journal that communicates medical information to physicians, other health professionals. Journals that cover many medical specialties are sometimes called general medical journals.
History
The first ...
covering
pediatric psychiatry
Child and adolescent psychiatry (or pediatric psychiatry) is a branch of psychiatry that focuses on the diagnosis, treatment, and prevention of mental disorders in children, adolescents, and their families. It investigates the biopsychosocial fact ...
. It is published by
Elsevier and is the official journal of the
American Academy of Child and Adolescent Psychiatry. The
editor-in-chief is Douglas Novins.
According to the ''
Journal Citation Reports'', its 2014
impact factor is 7.26, ranking it first among 119 journals in the category "Pediatrics".
It is abstracted and indexed in
MEDLINE/
PubMed, and
Science Citation Index.
Call for retraction
The group
Healthy Skepticism
Healthy Skepticism Inc is an international non-profit organisation whose main aim is to "improve health by reducing harm from misleading drug promotion".
Healthy Skepticism was founded in 1983 with the name Medical Lobby for Appropriate Marketi ...
has accused the journal of having published an article, in 2001, that misrepresented the results of an industry-sponsored clinical trial,
study 329
Study 329 was a clinical trial which was conducted in North America from 1994 to 1998 to study the efficacy of paroxetine, an SSRI anti-depressant, in treating 12- to 18-year-olds diagnosed with major depressive disorder. Led by Martin Keller, t ...
. The study examined the use of
paroxetine by teenagers. The trial was sponsored by, and ghostwritten on behalf of, SmithKline Beecham (now
GlaxoSmithKline
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. GSK is the ten ...
), and is widely regarded as having downplayed the trial's negative results. ''JAACAP'' editors have declined to retract the article, arguing that the negative results are available in the article, and that therefore there are no grounds for retraction. This claim is disputed on the basis that primary and secondary outcomes for efficacy were manipulated and safety results were obscured or omitted. Critics therefore argue that the Journal's editors have failed to uphold the scientific standards of clinical research by failing to retract a fraudulent article.
[ Leemon B. McHenry, Jon N. Jureidini, "Industry-sponsored ghostwriting in clinical trial reporting: a case study," ''Accountability in Research: Policies and Quality Assurance'', 15(3), July–September 2008, pp. 152–167. ]
References
External links
* {{Official, http://www.jaacap.com/
English-language journals
Elsevier academic journals
Pediatrics journals
Psychiatry journals
Developmental psychology journals
Monthly journals
Publications established in 1987
Child and adolescent psychiatry journals